Skip to main content
. 2017 Apr 10;9(6):770–785. doi: 10.15252/emmm.201607096

Figure EV3. Chronic STA treatment improves glucose tolerance and reduces plasma TG levels and cardiac LPO.

Figure EV3

  1. PI5P levels were quantified in cardiac tissue by mass assay to monitor the efficacy of STA treatment in obese mice.
  2. Glucose tolerance test was performed on 6‐h‐fasted obese vehicle‐ or STA‐treated mice.
  3. Area under the curve of glucose tolerance test from (B).
  4. Plasma triglycerides (TG) levels were quantified from vehicle‐ or STA‐treated obese mice.
  5. Lipid peroxide (LPO) was quantified in cardiac tissue.
Data information: Data are presented as mean ± SEM. Student's t‐test, ***P < 0.001, **P < 0.01, *P < 0.05. n = 5–6 mice per group.